The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of weekly nab-paclitaxel with GM-CSF as an immune modulator in recurrent platinum resistant ovarian, fallopian tube, and primary peritoneal cancer: Clinical and immune responses.
 
John Ben Liao
No Relationships to Disclose
 
Ron E. Swensen
No Relationships to Disclose
 
Jessica Reichow
No Relationships to Disclose
 
Kelsie J Ovenell
No Relationships to Disclose
 
Jennifer Childs
No Relationships to Disclose
 
Doreen Higgins
No Relationships to Disclose
 
Barbara Buening
No Relationships to Disclose
 
Barbara Ann Goff
No Relationships to Disclose
 
Chihiro Morishima
No Relationships to Disclose
 
Mary L. Disis
Stock and Other Ownership Interests - Epithany; VentiRx
Consulting or Advisory Role - Celgene; EMD Serono; Emergent BioSolutions; VentiRx
Research Funding - Seagen; VentiRx
Patents, Royalties, Other Intellectual Property - I am an inventor on patents held by the University of Washington